Company / Cash per Share
PULSE BIOSCIENCES, INC. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$1.22
FY2025
5-year range
$1.12 / $2.14
FY2021-FY2025
Trend
-42.8%
vs FY2024
Sector context
#111 of 146
Health Care
What the data says
PULSE BIOSCIENCES, INC.'s cash per share of $1.22 is lower than 76% of companies in the Health Care sector (FY2025). Cash per Share has fluctuated over the past 10 years, ranging from $0.19 in FY2016 to $2.99 in FY2018.
Based on SEC 10-K filings.
1.22 in FY2025 with a 5-year CAGR of +18.0%.
Improved from $1.19 to $1.22 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -15.9%
- 5-Year CAGR
- +18.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 24% in Health CareTop 76% of 146This company $1.22 Sector average $27.70
▼
-95.6% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 42.8% year-over-year.
- Ranks #111 out of 146 companies in the Health Care sector.
- Peak cash per share was recorded in FY2018.
- Lowest cash per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.66 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.22 | -42.8% |
| FY2024 | $2.14 | +79.7% |
| FY2023 | $1.19 | -42.1% |
| FY2022 | $2.06 | +83.7% |
| FY2021 | $1.12 | +108.9% |
| FY2020 | $0.54 | +61.2% |
| FY2019 | $0.33 | -88.9% |
| FY2018 | $2.99 | +1203.9% |
| FY2017 | $0.23 | +20.9% |
| FY2016 | $0.19 | -60.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026